In addition, when HNSCC samples were stratified according to HPV− (n = 421) and HPV+ (n = 97) status, a significantly higher (p < 0.001) expression of IDO1 was observed in HPV+ compared to HPV− tumors (Figure 1A). Here, IDO1 is linked to head and neck squamous cell carcinoma.